2m 2m 2m 2m 2m 2m 2m
INCANNEX HEAL (IXHL)
NASDAQ
$2.63+$0.03 (+1.27%)
Price as of Oct 23, 2026 6:32 PM EDT- $31.1MMarket Cap
- -74.58%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
INCANNEX HEAL (IXHL)
$2.63+$0.03 (+1.27%)
IXHL | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.60 | ||
Change | -$0.16 (-5.80%) | ||
Open | $2.73 | ||
High | $2.75 | ||
Low | $2.55 | ||
Previous Close | $2.76 | ||
Volume | 138,400 | ||
30-Day Average Volume | 68,111 | ||
1-Week Change | -9.72% | ||
1-Month Change | -23.42% | ||
1-Year Change | -74.58% | ||
3-Year Change | -90.37% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 12.0M | ||
Total Assets | $73.0M | ||
Market Cap | $31.1M | ||
Enterprise Value | -$36.5M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$2.5M | ||
Free Cash Flow | $3.4M | ||
EBIT | -$2.5M | ||
EBITDA | -$2.4M | ||
Net Working Capital | $71.3M | ||
EPS | $0.00 | ||
Enterprise Value/EBITDA | 15 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 0 | ||
P/E | 667 | ||
PEG | 7 | ||
Price/Free Cash Flow | 9 | ||
Price/Operating Cash Flow | 9 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 30 | ||
Last Split Date | 02/27/2026 | ||
Earnings & Revenue